Imidazoliums with proximal phosphines undergo C−H oxidative addition on [Ir(COD)Cl] 2 to give iridium(III) abnormal carbene hydrides. The effects of the length of the linker between the imidazolium and the phosphine are systematically studied. These C−H activation products can undergo base-promoted H−Cl reductive elimination to afford the corresponding Ir(I) abnormal NHC complexes.
No takes yet. Share an insight, caveat, or question.
Song et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: